Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 3 studies | 61% ± 14% | |
epithelial cell of proximal tubule | 3 studies | 39% ± 11% |
Insufficient scRNA-seq data for expression of SLC28A1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 3687.75 | 89 / 89 | 88% | 103.10 | 789 / 901 |
liver | 100% | 6278.00 | 226 / 226 | 77% | 28.70 | 314 / 406 |
muscle | 98% | 67.01 | 784 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 50.11 | 832 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 92% | 39.84 | 1234 / 1335 | 0% | 0 | 0 / 0 |
breast | 78% | 19.92 | 358 / 459 | 3% | 0.25 | 37 / 1118 |
uterus | 73% | 18.15 | 124 / 170 | 1% | 0.05 | 4 / 459 |
adipose | 72% | 13.09 | 866 / 1204 | 0% | 0 | 0 / 0 |
intestine | 54% | 225.53 | 523 / 966 | 1% | 0.09 | 4 / 527 |
prostate | 52% | 6.38 | 127 / 245 | 0% | 0.01 | 1 / 502 |
adrenal gland | 52% | 6.38 | 134 / 258 | 0% | 0 | 0 / 230 |
bladder | 43% | 3.76 | 9 / 21 | 1% | 0.03 | 4 / 504 |
spleen | 44% | 11.76 | 105 / 241 | 0% | 0 | 0 / 0 |
pancreas | 42% | 4.85 | 137 / 328 | 1% | 0.06 | 1 / 178 |
ovary | 38% | 4.01 | 69 / 180 | 3% | 0.13 | 12 / 430 |
thymus | 39% | 3.83 | 254 / 653 | 0% | 0.01 | 1 / 605 |
esophagus | 35% | 3.98 | 500 / 1445 | 1% | 0.04 | 2 / 183 |
brain | 31% | 3.86 | 829 / 2642 | 3% | 0.23 | 20 / 705 |
lung | 30% | 2.99 | 172 / 578 | 1% | 0.03 | 7 / 1155 |
stomach | 26% | 3.18 | 93 / 359 | 0% | 0 | 0 / 286 |
peripheral blood | 25% | 3.72 | 234 / 929 | 0% | 0 | 0 / 0 |
skin | 18% | 1.87 | 317 / 1809 | 1% | 0.05 | 3 / 472 |
eye | 0% | 0 | 0 / 0 | 5% | 0.25 | 4 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1904823 | Biological process | purine nucleobase transmembrane transport |
GO_0015861 | Biological process | cytidine transport |
GO_0015855 | Biological process | pyrimidine nucleobase transport |
GO_0072531 | Biological process | pyrimidine-containing compound transmembrane transport |
GO_0045117 | Biological process | azole transmembrane transport |
GO_0015862 | Biological process | uridine transmembrane transport |
GO_0180015 | Biological process | nucleoside import across plasma membrane |
GO_1901642 | Biological process | nucleoside transmembrane transport |
GO_0031526 | Cellular component | brush border membrane |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016607 | Cellular component | nuclear speck |
GO_0005829 | Cellular component | cytosol |
GO_0005415 | Molecular function | nucleoside:sodium symporter activity |
GO_0005345 | Molecular function | purine nucleobase transmembrane transporter activity |
GO_1901474 | Molecular function | azole transmembrane transporter activity |
GO_0015389 | Molecular function | pyrimidine- and adenosine-specific:sodium symporter activity |
GO_0015213 | Molecular function | uridine transmembrane transporter activity |
GO_0015212 | Molecular function | cytidine transmembrane transporter activity |
Gene name | SLC28A1 |
Protein name | Solute carrier family 28 member 1 (cDNA FLJ58165, highly similar to Sodium/nucleoside cotransporter 1) Sodium/nucleoside cotransporter 1 (Concentrative nucleoside transporter 1) (CNT 1) (hCNT1) (Na(+)/nucleoside cotransporter 1) (Sodium-coupled nucleoside transporter 1) (Solute carrier family 28 member 1) |
Synonyms | CNT1 |
Description | FUNCTION: Sodium and pyrimidine nucleoside symporter of the plasma membrane that imports uridine, thymidine and cytidine into cells by coupling their transport to the transmembrane sodium electrochemical gradient. Also transports adenosine, an atypical substrate transported with high apparent affinity, but low maximum velocity. Therefore, exhibits the transport characteristics of the nucleoside transport system cit or N2 subtype (N2/cit) . Involved in renal nucleoside (re)absorption . . |
Accessions | O00337 ENST00000286749.3 [O00337-1] B7Z3L6 ENST00000538177.5 ENST00000338602.6 [O00337-2] ENST00000394573.6 [O00337-1] |